Circular CRISPR Edits Human Pluripotent Stem Cells for Disease Modeling.

Area of Science:

• Biotechnology
• Stem Cell Research
• Gene Editing

Background:

• CRISPR technology is a key tool for human pluripotent stem cell (hPSC) disease modeling.
• RNA-based gene editing faces challenges with immunogenicity and stability in vivo.
• Developing stable and less immunogenic editing systems is crucial for therapeutic applications.

Purpose of the Study:

• To describe the process of circularizing guide RNA and CRISPR base editing elements for hPSC disease modeling.
• To establish a reliable and low-immunogenic method for gene point editing in stem cells.
• To provide guidance for constructing gene-edited cell lines for research and therapeutic development.

Main Methods:

• Circularization of guide RNA and CRISPR base editing components.
• Application of circularized elements for editing in human pluripotent stem cells.
• Establishment of disease models using gene-edited stem cells.

Main Results:

• Successful circularization of guide RNA and CRISPR base editing elements.
• Demonstration of effective gene point editing in hPSCs using the circularized system.
• Creation of stem cell disease models with improved editing efficiency and reduced immunogenicity.

Conclusions:

• Circular RNA technology offers a stable and low-immunogenic alternative for CRISPR base editing in hPSCs.
• This method provides a robust platform for disease modeling and advancing gene therapy research.
• The study offers practical guidance for constructing gene-edited cell lines.